Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA)
DNA Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-17.90%
Analyst Rating:
HOLD
Analyst Forecast (1yr):
-51.30%
DNA Stock Analysis
DNA
PE Ratio:
DNA
PEG Ratio:
Not Available
DNA
Forward EPS Growth (12 month):
0.00%
DNA
PS Ratio:
4
DNA
PSG Ratio:
-0.3
DNA
Forward Revenue Growth (12 month):
-14.40%
DNA Articles
No data was found